Amgen News

With a week left to match a challenge from the Amgen Foundation, a fund drive paying for basic needs of Ventura County residents has raised more than $130,000. The money is being given to The Buck Starts Here, a campaign aimed at helping local residents survive in a time of double-digit unemployment.

Managers in money management firm PRIMECAP Management Company prefer to stay behind the scene, focusing on money management and letting the other people to do the marketing for them.

In his article " The Market's 10 Best Stocks ," my colleague Tim Hanson pointed out the benefits of searching for the next multibagger success stories among the smallest of companies.

Drugmaker ImmunoGen Inc said it licensed its technology to develop anti-cancer drugs to Amgen Inc for a $1 million upfront payment.

Waltham biotechnology firm ImmunoGen Inc. has announced a second license granted to Amgen Inc.

ImmunoGen Inc. said Thursday that Amgen Inc. licensed rights to a second potential cancer-treatment from the company for $1 million upfront.

While the market has staged a nice comeback since the spring and the economy seems to be slowly righting itself, things are still rough out there.

Rule Breaker . As long as I live, I'll never forget the day I first heard those two words.

Keith Leonard, founder of Kythera Biopharmaceuticals Inc. in Calabasas, said his degrees in engineering, business and history helped him launch a biotechnology company, but the ultimate decision was determined by an emotional readiness and a broad work experience.

Over his 28 years, Burrill's clients have included Steve Jobs of Apple, Genentech, Amgen and Gilead Sciences.

Vectibix, a cancer drug made by Amgen , did not show statistically significant survival rates for patients in a study of its effectiveness against advanced colorectal cancer.

A lawsuit launched against Amgen Inc. on Oct. 30 raises important questions about what is accepted practice when it comes to manufacturing and administering certain drugs and whether the company encouraged the fraudulent sale of free drugs to increase their use.

IA could write this article the usual way -- byA showing you how to turn your thousands into millionsA through investments in solid, well-known companies.

Wesely-Thomas Enterprises CEO Carl Wesely takes a look around an operating room at Los Robles Hospital & Medical Center in Thousand Oaks on Friday.

Although Amgen Inc.'s Phase III Vectibix-Folfox combination met its main goal - to improve progression-free survival in patients with advanced colorectal cancer in the first-line setting - it missed its secondary endpoint of overall survival, the company reported Thursday.

Amgen today announced that the Phase 3 PRIME "203" trial evaluating Vectibix administered in combination with FOLFOX as a first-line treatment of metastatic colorectal cancer failed to meet a secondary endpoint of overall survival.

Amylin Pharmaceuticals Inc. says it could potentially receive more than $1 billion from a partnership with Japan's Takeda Pharmaceutical Co.

Hawaii is one of several states suing biotechnology behemoth Amgen Inc. for allegedly giving kickbacks to medical providers to help boost sales of the anemia drug Aranesp.

Amgen Inc., the world's largest biotechnology company, is being sued by Indiana, New York and 13 other states following an investigation into a national kickback scheme to boost drug sales, New York Attorney General Andrew Cuomo said.

Stock-PR.com, a division of Crown Equity Holdings Inc. tracks stocks daily and is pleased to offer its hot stock alerts.